GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » C21 Investments Inc (XCNQ:CXXI) » Definitions » EV-to-Revenue

C21 Investments (XCNQ:CXXI) EV-to-Revenue : 1.69 (As of May. 26, 2024)


View and export this data going back to 1987. Start your Free Trial

What is C21 Investments EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, C21 Investments's enterprise value is C$65.45 Mil. C21 Investments's Revenue for the trailing twelve months (TTM) ended in Oct. 2023 was C$38.71 Mil. Therefore, C21 Investments's EV-to-Revenue for today is 1.69.

The historical rank and industry rank for C21 Investments's EV-to-Revenue or its related term are showing as below:

XCNQ:CXXI' s EV-to-Revenue Range Over the Past 10 Years
Min: -25.64   Med: 1.34   Max: 161.42
Current: 1.69

During the past 13 years, the highest EV-to-Revenue of C21 Investments was 161.42. The lowest was -25.64. And the median was 1.34.

XCNQ:CXXI's EV-to-Revenue is ranked better than
63.57% of 1024 companies
in the Drug Manufacturers industry
Industry Median: 2.285 vs XCNQ:CXXI: 1.69

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-26), C21 Investments's stock price is C$0.455. C21 Investments's Revenue per Share for the trailing twelve months (TTM) ended in Oct. 2023 was C$0.32. Therefore, C21 Investments's PS Ratio for today is 1.44.


C21 Investments EV-to-Revenue Historical Data

The historical data trend for C21 Investments's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C21 Investments EV-to-Revenue Chart

C21 Investments Annual Data
Trend Jan14 Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 33.15 2.00 4.99 2.15 1.41

C21 Investments Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.35 1.41 1.40 1.48 1.37

Competitive Comparison of C21 Investments's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, C21 Investments's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


C21 Investments's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, C21 Investments's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where C21 Investments's EV-to-Revenue falls into.



C21 Investments EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

C21 Investments's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=65.453/38.711
=1.69

C21 Investments's current Enterprise Value is C$65.45 Mil.
C21 Investments's Revenue for the trailing twelve months (TTM) ended in Oct. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$38.71 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


C21 Investments  (XCNQ:CXXI) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

C21 Investments's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.455/0.315
=1.44

C21 Investments's share price for today is C$0.455.
C21 Investments's Revenue per Share for the trailing twelve months (TTM) ended in Oct. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.32.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


C21 Investments EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of C21 Investments's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


C21 Investments (XCNQ:CXXI) Business Description

Traded in Other Exchanges
Address
601 West Cordova Street, Suite 280, Vancouver, BC, CAN, V6B 1G1
C21 Investments Inc is a vertically integrated cannabis company. It cultivates, processes, manufactures, and distributes cannabis and hemp-derived consumer products. C21's focus is to expand where the company can wholly own indoor or outdoor cultivation operations, extraction facilities, bakeries, branded products, and retail dispensaries with a large distribution network.
Executives
Bruce Macdonald Director

C21 Investments (XCNQ:CXXI) Headlines

No Headlines